Skip to main content
. Author manuscript; available in PMC: 2018 Jul 4.
Published in final edited form as: Chembiochem. 2017 Apr 4;18(13):1226–1233. doi: 10.1002/cbic.201600702

Figure 1.

Figure 1

Antigen-specific liposome formulations with CD22 ligand and rapamycin. (A) Chemical structures of the murine CD22 ligand linked to PEGylated lipid (1) and rapamycin (2). (B) Schematic illustration of antigen-specific liposome formulations equipped with CD22 ligand (STALs) and the new platform (STALs+RAPA).